Non-invasive Monitoring of Miscarriage
ConditionMiscarriage in First Trimester
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-45
SponsorChinese University of Hong Kong
About this trial
cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.
Eligibility criteria
Qualifiers
Age 18-45 years.
Women who attend the early pregnancy loss clinic or Patients who receive ART
Their partner, the biological father of the pregnancy
Disqualifiers
History of psychological/ psychiatric problem
Patient refusal
Trial design
Treatments tested in this trial
- This is a routine procedure, no intervention will be provided.
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov